Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pharmacology

279. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID)

Molecular Therapy

English

646. Viral Spread of Adenovirus Serotype 5 Versus Serotype 3 in Epithelial Tumors

English

Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin Α2 Surrogates

English

482. Bid Is a Key Factor for Eliciting the Antiproliferative Activity of IFN-aL Mediated by TRAIL

English

In This Issue

English

274. Eag1 Gene Silencing by Non-Viral Expression Vector Reduces the Viability of Neuroblastoma Cells in Culture

English

In Vitro and in Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma

English

78. Overexpression of Non-Aggregatable Alpha-Synuclein Protects Against Human Wildtype Alpha-Synuclein Mediated Toxicity

English

412. The Efficacy and Bio-Distribution of Oncolytic HSV-1 (G47Δ) in Mouse Orthotopic Esophageal Cancer Models

English

242. Genomic Analyses Define a Common Integration Site in Hepatocellular Carcinoma Caused by Therapeutic AAV Gene Delivery: A Mouse-Specific Phenomenon or New Safety Challenge for Human Gene Therapy?

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pharmacology

279. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID)

646. Viral Spread of Adenovirus Serotype 5 Versus Serotype 3 in Epithelial Tumors

Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin Α2 Surrogates

482. Bid Is a Key Factor for Eliciting the Antiproliferative Activity of IFN-aL Mediated by TRAIL

In This Issue

274. Eag1 Gene Silencing by Non-Viral Expression Vector Reduces the Viability of Neuroblastoma Cells in Culture

In Vitro and in Vivo Efficacy of SYL040012, a Novel siRNA Compound for Treatment of Glaucoma

78. Overexpression of Non-Aggregatable Alpha-Synuclein Protects Against Human Wildtype Alpha-Synuclein Mediated Toxicity

412. The Efficacy and Bio-Distribution of Oncolytic HSV-1 (G47Δ) in Mouse Orthotopic Esophageal Cancer Models

242. Genomic Analyses Define a Common Integration Site in Hepatocellular Carcinoma Caused by Therapeutic AAV Gene Delivery: A Mouse-Specific Phenomenon or New Safety Challenge for Human Gene Therapy?